Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur Μ. Krieg, Jürgen Vollmer
Immunological Reviews (2007) Vol. 220, Iss. 1, pp. 251-269
Closed Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Manuel G. Cosío, Marina Saetta, Àlvar Agustí
New England Journal of Medicine (2009) Vol. 360, Iss. 23, pp. 2445-2454
Open Access | Times Cited: 784
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lan Lin, Jianqiong Zhang
BMC Immunology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 633
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kužnik, Mojca Benčina, Urban Švajger, et al.
The Journal of Immunology (2011) Vol. 186, Iss. 8, pp. 4794-4804
Open Access | Times Cited: 575
Follicular helper T cells are required for systemic autoimmunity
Michelle A. Linterman, Robert J. Rigby, Raphael. K. Wong, et al.
The Journal of Experimental Medicine (2009) Vol. 206, Iss. 3, pp. 561-576
Open Access | Times Cited: 570
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Ulrich Lächelt, Ernst Wagner
Chemical Reviews (2015) Vol. 115, Iss. 19, pp. 11043-11078
Closed Access | Times Cited: 559
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Jürgen Vollmer, Arthur Μ. Krieg
Advanced Drug Delivery Reviews (2009) Vol. 61, Iss. 3, pp. 195-204
Closed Access | Times Cited: 549
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
Luke O'neill, Clare Bryant, Sarah Doyle
Pharmacological Reviews (2009) Vol. 61, Iss. 2, pp. 177-197
Open Access | Times Cited: 411
Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics
Jean‐Laurent Casanova, Laurent Abel, Lluís Quintana‐Murci
Annual Review of Immunology (2011) Vol. 29, Iss. 1, pp. 447-491
Closed Access | Times Cited: 346
TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
Kevin M. Nickerson, Sean R. Christensen, Jonathan Shupe, et al.
The Journal of Immunology (2010) Vol. 184, Iss. 4, pp. 1840-1848
Open Access | Times Cited: 319
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann, Dennis M. Klinman
Vaccine (2014) Vol. 32, Iss. 48, pp. 6377-6389
Open Access | Times Cited: 302
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
Thiruma V. Arumugam, Eitan Okun, Sung‐Chun Tang, et al.
Shock (2009) Vol. 32, Iss. 1, pp. 4-16
Open Access | Times Cited: 291
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
Sarah E. Ewald, Alex Engel, Jiyoun Lee, et al.
The Journal of Experimental Medicine (2011) Vol. 208, Iss. 4, pp. 643-651
Open Access | Times Cited: 291
PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling
Xinming Cai, YongYao Xu, Atwood K. Cheung, et al.
Chemistry & Biology (2013) Vol. 20, Iss. 7, pp. 912-921
Open Access | Times Cited: 206
An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway
Zhenzhen Feng, Gui Chen, Min Zhong, et al.
Biomaterials (2023) Vol. 302, pp. 122333-122333
Closed Access | Times Cited: 73
Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications
Yi-Hsin Chen, Kang‐Hsi Wu, Han‐Ping Wu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5037-5037
Open Access | Times Cited: 17
Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling
Yue Guan, Diana Rose E. Rañoa, Song Jiang, et al.
The Journal of Immunology (2010) Vol. 184, Iss. 9, pp. 5094-5103
Open Access | Times Cited: 246
The interferon-α signature of systemic lupus erythematosus
Gerlinde Obermoser, Virginia Pascual
Lupus (2010) Vol. 19, Iss. 9, pp. 1012-1019
Open Access | Times Cited: 213
Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications
Manuel T. Silva, Ana do Vale, Nuno M.S. dos Santos
APOPTOSIS (2008) Vol. 13, Iss. 4, pp. 463-482
Open Access | Times Cited: 211
CD14 is a coreceptor of Toll-like receptors 7 and 9
Christoph Baumann, Irene M. Aspalter, Omar Sharif, et al.
The Journal of Experimental Medicine (2010) Vol. 207, Iss. 12, pp. 2689-2701
Open Access | Times Cited: 210
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
Evelien Smits, Peter Ponsaerts, Zwi Berneman, et al.
The Oncologist (2008) Vol. 13, Iss. 8, pp. 859-875
Open Access | Times Cited: 206
Polyvalent Immunostimulatory Nanoagents with Self‐Assembled CpG Oligonucleotide‐Conjugated Gold Nanoparticles
Min Wei, Nan Chen, Jiang Li, et al.
Angewandte Chemie International Edition (2011) Vol. 51, Iss. 5, pp. 1202-1206
Closed Access | Times Cited: 193
CpG Still Rocks! Update on an Accidental Drug
Arthur Μ. Krieg
Nucleic Acid Therapeutics (2012) Vol. 22, Iss. 2, pp. 77-89
Closed Access | Times Cited: 177
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion
Zubin M. Bamboat, Lee M. Ocuin, Vinod P. Balachandran, et al.
Journal of Clinical Investigation (2010) Vol. 120, Iss. 2, pp. 559-569
Open Access | Times Cited: 176
Adaptation and Constraint at Toll-Like Receptors in Primates
Gabriela Wlasiuk, Michael W. Nachman
Molecular Biology and Evolution (2010) Vol. 27, Iss. 9, pp. 2172-2186
Open Access | Times Cited: 175
Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Hidekazu Shirota, Dennis M. Klinman
Expert Review of Vaccines (2013) Vol. 13, Iss. 2, pp. 299-312
Open Access | Times Cited: 158
Page 1 - Next Page

Scroll to top